With regard to the establishment of the Canadian Drug Agency proposed in Budget 2019: (a) where is the Canadian Drug Agency, or the transition office set up to create the Agency, located; (b) will the Agency be a stand-alone Agency or a division of Health Canada; (c) how many employees or full-time equivalents are currently assigned to the Agency or the establishment of the Agency; (d) which government official is responsible for overseeing the creation of the Agency; and (e) what are the details of all consultations the government has conducted in relation to the Agency, including (i) name of organization, individual, or provincial government consulted, (ii) date, (iii) type of consultation, (iv) results of consultation?
In the House of Commons on June 19th, 2019. See this statement in context.